Cargando…
Determination of dosimetric parameters for shielded (153)Gd source in prostate cancer brachytherapy
BACKGROUND: Interstitial rotating shield brachytherapy (I-RSBT) is a recently developed method for treatment of prostate cancer. In the present study TG-43 dosimetric parameters of a (153)Gd source were obtained for use in I-RSBT. MATERIALS AND METHODS: A (153)Gd source located inside a needle inclu...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5330175/ https://www.ncbi.nlm.nih.gov/pubmed/28265239 http://dx.doi.org/10.1515/raon-2017-0009 |
_version_ | 1782511210564943872 |
---|---|
author | Ghorbani, Mahdi Khajetash, Benyamin Ghatei, Najmeh Mehrpouyan, Mohammad Meigooni, Ali S. Shahraini, Ramin |
author_facet | Ghorbani, Mahdi Khajetash, Benyamin Ghatei, Najmeh Mehrpouyan, Mohammad Meigooni, Ali S. Shahraini, Ramin |
author_sort | Ghorbani, Mahdi |
collection | PubMed |
description | BACKGROUND: Interstitial rotating shield brachytherapy (I-RSBT) is a recently developed method for treatment of prostate cancer. In the present study TG-43 dosimetric parameters of a (153)Gd source were obtained for use in I-RSBT. MATERIALS AND METHODS: A (153)Gd source located inside a needle including a Pt shield and an aluminum window was simulated using MCNPX Monte Carlo code. Dosimetric parameters of this source model, including air kerma strength, dose rate constant, radial dose function and 2D anisotropy function, with and without the shields were calculated according to the TG-43 report. RESULTS: The air kerma strength was found to be 6.71 U for the non-shielded source with 1 GBq activity. This value was found to be 0.04 U and 6.19 U for the Pt shield and Al window cases, respectively. Dose rate constant for the non-shielded source was found to be 1.20 cGy/(hU). However, for a shielded source with Pt and aluminum window, dose rate constants were found to be 0.07 cGy/(hU) and 0.96 cGy/(hU), on the shielded and window sides, respectively. The values of radial dose function and anisotropy function were tabulated for these sources. Additionally, isodose curves were drawn for sources with and without shield, in order to evaluate the effect of shield on dose distribution. CONCLUSIONS: Existence of the Pt shield may greatly reduce the dose to organs at risk and normal tissues which are located toward the shielded side. The calculated air kerma strength, dose rate constant, radial dose function and 2D anisotropy function data for the (153)Gd source for the non-shielded and the shielded sources can be used in the treatment planning system (TPS). |
format | Online Article Text |
id | pubmed-5330175 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | De Gruyter |
record_format | MEDLINE/PubMed |
spelling | pubmed-53301752017-03-07 Determination of dosimetric parameters for shielded (153)Gd source in prostate cancer brachytherapy Ghorbani, Mahdi Khajetash, Benyamin Ghatei, Najmeh Mehrpouyan, Mohammad Meigooni, Ali S. Shahraini, Ramin Radiol Oncol Research Article BACKGROUND: Interstitial rotating shield brachytherapy (I-RSBT) is a recently developed method for treatment of prostate cancer. In the present study TG-43 dosimetric parameters of a (153)Gd source were obtained for use in I-RSBT. MATERIALS AND METHODS: A (153)Gd source located inside a needle including a Pt shield and an aluminum window was simulated using MCNPX Monte Carlo code. Dosimetric parameters of this source model, including air kerma strength, dose rate constant, radial dose function and 2D anisotropy function, with and without the shields were calculated according to the TG-43 report. RESULTS: The air kerma strength was found to be 6.71 U for the non-shielded source with 1 GBq activity. This value was found to be 0.04 U and 6.19 U for the Pt shield and Al window cases, respectively. Dose rate constant for the non-shielded source was found to be 1.20 cGy/(hU). However, for a shielded source with Pt and aluminum window, dose rate constants were found to be 0.07 cGy/(hU) and 0.96 cGy/(hU), on the shielded and window sides, respectively. The values of radial dose function and anisotropy function were tabulated for these sources. Additionally, isodose curves were drawn for sources with and without shield, in order to evaluate the effect of shield on dose distribution. CONCLUSIONS: Existence of the Pt shield may greatly reduce the dose to organs at risk and normal tissues which are located toward the shielded side. The calculated air kerma strength, dose rate constant, radial dose function and 2D anisotropy function data for the (153)Gd source for the non-shielded and the shielded sources can be used in the treatment planning system (TPS). De Gruyter 2017-02-22 /pmc/articles/PMC5330175/ /pubmed/28265239 http://dx.doi.org/10.1515/raon-2017-0009 Text en © 2017 Radiol Oncol |
spellingShingle | Research Article Ghorbani, Mahdi Khajetash, Benyamin Ghatei, Najmeh Mehrpouyan, Mohammad Meigooni, Ali S. Shahraini, Ramin Determination of dosimetric parameters for shielded (153)Gd source in prostate cancer brachytherapy |
title | Determination of dosimetric parameters for shielded (153)Gd source in prostate cancer brachytherapy |
title_full | Determination of dosimetric parameters for shielded (153)Gd source in prostate cancer brachytherapy |
title_fullStr | Determination of dosimetric parameters for shielded (153)Gd source in prostate cancer brachytherapy |
title_full_unstemmed | Determination of dosimetric parameters for shielded (153)Gd source in prostate cancer brachytherapy |
title_short | Determination of dosimetric parameters for shielded (153)Gd source in prostate cancer brachytherapy |
title_sort | determination of dosimetric parameters for shielded (153)gd source in prostate cancer brachytherapy |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5330175/ https://www.ncbi.nlm.nih.gov/pubmed/28265239 http://dx.doi.org/10.1515/raon-2017-0009 |
work_keys_str_mv | AT ghorbanimahdi determinationofdosimetricparametersforshielded153gdsourceinprostatecancerbrachytherapy AT khajetashbenyamin determinationofdosimetricparametersforshielded153gdsourceinprostatecancerbrachytherapy AT ghateinajmeh determinationofdosimetricparametersforshielded153gdsourceinprostatecancerbrachytherapy AT mehrpouyanmohammad determinationofdosimetricparametersforshielded153gdsourceinprostatecancerbrachytherapy AT meigoonialis determinationofdosimetricparametersforshielded153gdsourceinprostatecancerbrachytherapy AT shahrainiramin determinationofdosimetricparametersforshielded153gdsourceinprostatecancerbrachytherapy |